Compounds > medroxyprogesterone acetate
Page last updated: 2024-08-17

medroxyprogesterone acetate and Adenocarcinoma, Scirrhous

medroxyprogesterone acetate has been researched along with Adenocarcinoma, Scirrhous in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's3 (60.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hasegawa, N; Iimura, Y; Kaneko, H; Kawabata, M; Konishi, K; Shoji, Y1
Hashiguchi, H; Hirooka, Y; Kamasako, A; Nozaka, K; Ohgami, Y; Otani, S; Takebayashi, M; Tanida, O; Toyota, N; Wakatsuki, T1
Hirakawa, K; Ishikawa, T; Kato, Y; Nakata, B; Ogawa, Y; Onoda, N; Takagaki, K; Takashima, T1
Kimura, M; Koida, T; Sekihara, M1
Kihara, M; Maeda, M; Matsusaka, K; Miyauchi, A1

Other Studies

5 other study(ies) available for medroxyprogesterone acetate and Adenocarcinoma, Scirrhous

ArticleYear
[A case of stage IV breast cancer with large cancer ulcer responding to combination therapy of capecitabine and medroxyprogesterone acetate and cyclophosphamide].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2009, Volume: 36, Issue:9

    Topics: Adenocarcinoma, Scirrhous; Administration, Oral; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Cyclophosphamide; Deoxycytidine; Female; Fluorouracil; Humans; Medroxyprogesterone Acetate; Middle Aged; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Skin Ulcer

2009
[Successful combination therapy with 5'-DFUR and MPA for breast cancer with spinal and vertebral metastases].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2004, Volume: 31, Issue:13

    Topics: Adenocarcinoma, Scirrhous; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Floxuridine; Fluorouracil; Humans; Magnetic Resonance Imaging; Mastectomy; Medroxyprogesterone Acetate; Middle Aged; Remission Induction; Spinal Cord Neoplasms; Spinal Neoplasms

2004
[A case of anthracycline and taxane-resistant breast cancer with life-thereatening multiple liver metastases responding to oral combination chemotherapy by UFT, cyclophosphamide and medroxyprogesterone acetate].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:5

    Topics: Adenocarcinoma, Scirrhous; Administration, Oral; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Bridged-Ring Compounds; Cyclophosphamide; Drug Administration Schedule; Drug Combinations; Drug Resistance, Neoplasm; Female; Humans; Liver Neoplasms; Medroxyprogesterone Acetate; Middle Aged; Taxoids; Tegafur; Uracil

2005
[A case of recurrent breast cancer responding to long-term treatment with 5'-DFUR combined with MPA].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1996, Volume: 23, Issue:9

    Topics: Adenocarcinoma, Scirrhous; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Administration Schedule; Female; Floxuridine; Humans; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Recurrence, Local

1996
[A case of stage IV breast cancer showing long-term complete response to combination therapy with 5'-DFUR and MPA].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1998, Volume: 25, Issue:13

    Topics: Adenocarcinoma, Scirrhous; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Combined Modality Therapy; Female; Floxuridine; Humans; Lymphatic Metastasis; Mastectomy; Medroxyprogesterone Acetate; Middle Aged; Remission Induction

1998